Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X.
Right arrow Articles by Gu, J.-r.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.
Right arrow Articles by Gu, J.-r.
[Cancer Research 61, 7383-7387, October 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

A Novel Growth Suppressor Gene on Chromosome 17p13.3 with a High Frequency of Mutation in Human Hepatocellular Carcinoma1

Xintai Zhao, Jinjun Li, Yinghua He, Fei Lan, Lili Fu, Jianying Guo, Ruijiao Zhao, Yun Ye, Mei He, Wenming Chong, Jianguo Chen, Lisheng Zhang, Nanwu Yang, Binghua Xu, Mengchao Wu, Dafang Wan and Jian-ren Gu2

National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai 200032 [X. Z., J. L., Y. H., F. L., L. F., J. G., R. Z., D. W., J. G.]; Shanghai GeneCore Bio Technologies Co., Ltd., Shanghai 200233 [Y. Y., M. H.]; Shanghai Research Center of Life Sciences, Shanghai 200031 [X. Z.]; Eastern Hepatobiliary Surgery Hospital, Shanghai 200433 [W. C., M. W.]; Qidong Liver Cancer Institute, Qidong 226200 [J. C., B. X.]; and Guangxi Cancer Institute, Guangxi 530021 [L. Z., N. Y.], China

Previous studies have shown that there is a high frequency of loss of heterozygosity (LOH) on chromosome 17p13.3 in hepatocellular carcinoma [HCC (M. Fujimori et al., Cancer Res., 51: 89–93, 1991; H. Nagai et al., Oncogene, 14: 2927–2933, 1997; V. Boige et al., Cancer Res., 57: 1986–1990, 1997; Z. Piao et al., Int. J. Cancer, 75: 29–33, 1998; and B. Charroux et al., J. Cell Biol., 148: 1177–1186, 2000)]. The minimum region of LOH on chromosome 17p13.3 in HCC has been defined within the region between D17S643 and D17S1574. Moreover, D17S926 in the minimum region of LOH has the highest frequency of LOH, and its sequencing analysis has been accomplished. In this region, 6 of 13 novel genes have been characterized (X. Zhao, D. Wan, M. He, Yu. Ye, Yi. He, L. Han, M. Guo, Y. Huang, W. Qin, M-W. Wang, W. Chong, J. Chen, L. Zhang, N. Yang, B. Xu, M. Wu, L. Zuo, and J. Gu. A high frequency LOH region on chromosome 17p13.3 in human HCC with densely clustered genes identified, submitted for publication). Here we describe the cloning and characterization of one of these novel genes, designated HCC suppressor 1 (HCCS1), located at this region. HCCS1 had 18 exons, and its full-length cDNA was 2.0 kb. The protein expression product of HCCS1 was located in mitochondria. HCCS1 had a high frequency of mutations in HCC samples, whereas no alteration has been found in matched noncancerous liver tissues. Immunohistochemistry revealed a significantly higher expression of HCCS1 in the noncancerous liver tissues (33 of 35 samples) than in the HCC samples (2 of 35 samples). Transfection of HCCS1 cDNA into the HCC cell line remarkably reduced the efficiency of its colony formation and inhibited tumor growth in nude mice. Taken together, these findings strongly suggest a potential role of HCCS1 as a HCC putative suppressor gene.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Klebig, S. Seitz, W. Arnold, N. Deutschmann, M. Pacyna-Gengelbach, S. Scherneck, and I. Petersen
Characterization of {gamma}-Aminobutyric Acid Type A Receptor-Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer
Cancer Res., January 15, 2005; 65(2): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Wan, Y. Gong, W. Qin, P. Zhang, J. Li, L. Wei, X. Zhou, H. Li, X. Qiu, F. Zhong, et al.
Large-scale cDNA transfection screening for genes related to cancer development and progression
PNAS, November 2, 2004; 101(44): 15724 - 15729.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-S. Jou, C.-S. Lee, Y.-H. Chang, C.-F. Hsiao, C.-F. Chen, C.-C. Chao, L. S.H. Wu, S.-H. Yeh, D.-S. Chen, and P.-J. Chen
Clustering of Minimal Deleted Regions Reveals Distinct Genetic Pathways of Human Hepatocellular Carcinoma
Cancer Res., May 1, 2004; 64(9): 3030 - 3036.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Di, J. Li, Y. Zhang, X. He, H. Lu, D. Xu, J. Ling, K. Huo, D. Wan, Y.-Y. Li, et al.
HCC-Associated Protein HCAP1, a Variant of GEMIN4, Interacts with Zinc-Finger Proteins
J. Biochem., June 1, 2003; 133(6): 713 - 718.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Farrand, B. Delahunt, X.-l. Wang, B. McIver, I. D. Hay, J. R. Goellner, N. L. Eberhardt, and S. K. G. Grebe
High Resolution Loss of Heterozygosity Mapping of 17p13 in Thyroid Cancer: Hurthle Cell Carcinomas Exhibit a Small 411-Kilobase Common Region of Allelic Imbalance, Probably Containing a Novel Tumor Suppressor Gene
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4715 - 4721.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.